Table 3.
Inflammatory biomarkers between low and high category of processed meat, red meat and white meat (g/d) in 391 obese and overweight women.
| Variables | Processed meat median | P -value | P -value† | Red meat median | P -value | P -value | White meat median | P -value | P -value† | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Low (<19.82) |
High
(>19.83) |
Low (<36.46) |
High
(>36.47) |
low (<31.02) |
High
(>31.03) |
||||||||
| HOMA-IR | Crude | 3.321 ± 1.411 | 3.172 ± 1.215 | 0.435 | 3.480 ± 1.400 | 3.201 ± 1.122 | 0.091 | 3.144 ± 1.215 | 3.530 ± 1.313 | 0.024 | |||
| Model 1 | 3.000 ± 00.315 | 2.921 ± 0.412 | 0.884 | 3.489 ± 0.261 | 2.626 ± 0.291 | 0.045 | 3.303 ± 0.284 | 2.865 ± 0.291 | 0.301 | ||||
| Model 2 | 2.937 ± 0.334 | 3.026 ± 0.443 | 0.882 | 3.511 ± 0.340 | 2.274 ± 0.392 | 0.045 | 3.104 ± 0.341 | 2.927 ± 0.374 | 0.610 | ||||
| Leptin (mg/L) | Crude | 26.301 ± 12.192 | 29.932 ± 11.170 | 0.164 | 27.436 ± 11.970 | 27.952 ± 11.922 | 0.846 | 27.894 ± 11.553 | 12.310 ± 1.832 | 0.882 | |||
| Model 1 | 25.923 ± 1.451 | 29.670 ± 1.865 | 0.124 | 27.184 ± 1.653 | 27.546 ± 1.616 | 0.884 | 27.640 ± 1.651 | 27.129 ± 1.581 | 0.821 | ||||
| Model 2 | 26.532 ± 1.475 | 28.711 ± 1.920 | 0.391 | 27.763 ± 1.642 | 27.004 ± 1.606 | 0.754 | 29.156 ± 1.654 | 25.660 ± 1.572 | 0.024 | ||||
| PAI1 (mg/L) | Crude | 17.081 ± 30.690 | 17.481 ± 30.695 | 0.950 | 12.845 ± 23.124 | 18.876 ± 34.841 | 0.201 | 13.580 ± 22.321 | 18.755 ± 36.312 | 0.270 | |||
| Model 1 | 7.920 ± 9.134 | 37.592 ± 12.041 | 0.07 | 15.574 ± 8.116 | 17.651 ± 8.970 | 0.860 | 13.722 ± 8.294 | 19.587 ± 8.723 | 0.631 | ||||
| Model 2 | 6.282 ± 9.231 | 40.230 ± 12.313 | 0.052 | 23.16 ± 11.055 | 14.33 ± 12.840 | 0.641 | 12.665 ± 10.310 | 26.690 ± 11.012 | 0.380 | ||||
| Gal-3 (mg/L) | Crude | 4.946 ± 1.320 | 5.594 ± 2.035 | 0.782 | 23.160 ± 11.051 | 14.332 ± 12.842 | 0.660 | 3.865 ± 5.867 | 4.665 ± 9.161 | 0.642 | |||
| Model 1 | 2.065 ± 1.532 | 6.961 ± 2.021 | 0.080 | 3.040 ± 1.396 | 3.874 ± 1.542 | 0.690 | 3.191 ± 1.421 | 3.66 ± 1.500 | 0.820 | ||||
| Model 2 | 1.800 ± 1.532 | 7.381 ± 2.040 | 0.054 | 4.371 ± 1.832 | 3.396 ± 2.132 | 0.750 | 3.100 ± 1.721 | 4.885 ± 1.833 | 0.511 | ||||
| Hs-CRP (mg/ L) | Crude | 4.622 ± 5.055 | 3.675 ± 3.771 | 0.220 | 4.540 ± 4.566 | 3.901 ± 4.575 | 0.284 | 4.211 ± 4.850 | 4.215 ± 4.270 | 0.991 | |||
| Model 1 | 2.531 ± 0.600 | 4.341 ± 0.791 | 0.091 | 5.574 ± 0.724 | 3.060 ± 0.801 | 0.031 | 4.435 ± 0.795 | 4.441 ± 0.834 | 0.990 | ||||
| Model 2 | 2.550 ± 0.622 | 5.31 ± 0.831 | 0.050 | 5.046 ± 0.775 | 3.384 ± 0.902 | 0.220 | 4.152 ± 0.754 | 4.494 ± 0.811 | 0.773 | ||||
| IL1b (mg/L) | Crude | 0.400 ± 0.532 | 0.301 ± 0.565 | 0.280 | 0.422 ± 0.492 | 0.321 ± 0.562 | 0.130 | 0.370 ± 0.535 | 0.375 ± 0.522 | 0.941 | |||
| Model 1 | 0.476 ± 0.091 | 0.176 ± 0.425 | 0.081 | 0.540 ± 0.080 | 0.172 ± 0.099 | 0.005 | 0.410 ± 0.094 | 0.333 ± 0.091 | 0.580 | ||||
| Model 2 | 0.462 ± 0.91 | 0.18 ± 0.135 | 0.130 | 0.517 ± 0.107 | 0.16 ± 0.1271 | 0.071 | 0.394 ± 0.105 | 0.315 ± 0.119 | 0.645 | ||||
| MCP-1 (mg/L) | Crude | 56.494 ± 96.055 | 56.340 ± 111.661 | 0.991 | 51.200 ± 104.101 | 50.901 ± 81.830 | 0.98 | 52.281 ± 95.400 | 49.815 ± 91.681 | 0.842 | |||
| Model 1 | 32.654 ± 22.971 | 108.901 ± 30.275 | 0.071 | 44.100 ± 21.360 | 63.850 ± 23.625 | 0.551 | 54.591 ± 22.003 | 51.324 ± 23.131 | 0.921 | ||||
| Model 2 | 29.584 ± 22.921 | 113.874 ± 30.565 | 0.046 | 64.051 ± 27.554 | 58.971 ± 32.001 | 0.910 | 54.743 ± 25.940 | 69.732 ± 27.704 | 0.711 | ||||
Gal-3, Galectin 3; Hs-CRP, high-sensitivity C-reactive protein; HOMA-IR, homeostasis model assessment of insulin resistance; IL-1b, interleukin 1 beta; MCP-1, chemoattractant protein-1; PA-1, plasminogen activator inhibitor-1; TGF-β, transforming growth factor.
Values are mean ± SD for the crude model and mean ± SE for an adjusted model.
Model 1: Adjusted for: age, BMI, physical activity, total energy intake, economic status, education, housing ownership.
Model 2: Additionally controlled for vegetables and dairy for processed meat.
The crude p-value for all variables obtained from the one-way analysis of variance (ANOVA).
Adjust p-value obtained from an analysis of covariance.
P < 0.05 consider as significant, P = 0.05–0.07 consider as marginally significant.
Bold values means significant p-value P < 0.05.